Past work on media coverage of candidates for political office has explored gender differences in quantity, substance, and tone with mixed results depending on the office, race, and context. We draw on the stereotype content model (SCM) to examine gendered patterns of media coverage of candidates on the trait dimensions of warmth and competence in the 2020 U.S. Democratic presidential primary. Combining Natural Language Processing and manual analysis of news, we find that female candidates receive more negative than positive warmth coverage, while male candidates receive more tonally balanced warmth coverage, which suggests that female leaders are penalized on the dimension of warmth. Additionally, white women received more warmth coverage than women of color and women of color receive more competence coverage than white women. The findings suggest news media may portray white women and women of color candidates as lacking gender congruent traits like warmth but may portray white women as possessing role congruent traits like competence.

Objectives: We describe a new evidence-based method for screening and evaluating emerging medical technologies. Washington State agencies, under legislative direction, have granted authority to its agency Medical Directors and policy leaders to make coverage decisions on medical technologies using a “dossier” process. The dossier process is employed when technology advocates or manufacturers request Washington State healthcare purchasers to pay for new and emerging technologies. This offers the advocate an opportunity to submit scientific evidence and information classically associated with a more formal health technology assessment.

Methods: The submitted information is independently reviewed and summarized for Washington State's public healthcare purchasers allowing a more standardized coverage decision for all public purchasers in Washington State.

Results: This process has allowed Washington State to make twelve evidence-based coverage decisions at a fraction of the cost of classic technology assessment. To date, of twelve reviews over 6 years, one health technology was approved for coverage, ten were not covered and one did not require a coverage decision.

Conclusions: This evidence-based dossier process has yielded high-value coverage decisions of new and emerging medical technologies for public healthcare purchasers in Washington State.